Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Dravet Syndrome Market, by Diagnosis
6.1 Introduction
6.2 Magnetic Resonance Imaging (MRI)
6.2.1 Market Estimates & Forecast, 2023 – 2030
6.3 Electroencephalography (EEG)
6.3.1 Market Estimates & Forecast, 2023 – 2030
6.4 SCN1A Testing
6.4.1 Market Estimates & Forecast, 2023 – 2030
6.5 Others
6.5.1 Market Estimates & Forecast, 2023 – 2030
Chapter 7. Global Dravet Syndrome Market, by Type of Seizures
7.1 Introduction
7.2 Myoclonic Seizures
7.2.1 Market Estimates & Forecast, 2023 – 2030
7.3 Atonic Seizures
7.3.1 Market Estimates & Forecast, 2023 – 2030
7.4 Partial Seizures
7.4.1 Market Estimates & Forecast, 2023 – 2030
7.5 Absence Seizures
7.5.1 Market Estimates & Forecast, 2023 – 2030
7.6 Tonic Clonic Seizures
7.6.1 Market Estimates & Forecast, 2023 – 2030
7.7 Photosensitive Seizures
7.7.1 Market Estimates & Forecast, 2023 – 2030
7.8 Others
7.8.1 Market Estimates & Forecast, 2023 – 2030
Chapter 8. Global Dravet Syndrome Market, by Treatment & Management
8.1 Introduction
8.2 Seizure Medications
8.2.1 Market Estimates & Forecast, 2023 – 2030
8.3 Ketogenic Diet
8.3.1 Market Estimates & Forecast, 2023 – 2030
8.4 Vagus Nerve Stimulation (VNS)
8.4.1 Market Estimates & Forecast, 2023 – 2030
8.5 Others
8.5.1 Market Estimates & Forecast, 2023 – 2030
Chapter 9. Global Dravet Syndrome Market, by End User
9.1 Introduction
9.2 Pharmaceutical Companies
9.2.1 Market Estimates & Forecast, 2023 – 2030
9.3 Hospitals
9.3.1 Market Estimates & Forecast, 2023 – 2030
9.4 Diagnostic Laboratories
9.4.1 Market Estimates & Forecast, 2023 – 2030
9.5 Academic and Research Institutes
9.5.1 Market Estimates & Forecast, 2023 – 2030
9.6 Academic and Research Institutes
9.6.1 Market Estimates & Forecast, 2023 – 2030
Chapter 10. Global Dravet Syndrome Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Biocodex
12.1.1 Company Overview
12.1.2 Diagnosis of Causative Agents Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Biscayne Neurotherapeutics
12.2.1 Company Overview
12.2.2 Diagnosis of Causative Agents Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 GW Pharmaceuticals, plc
12.3.1 Company Overview
12.3.2 Diagnosis of Causative Agents Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Zogenix, Inc
12.4.1 Company Overview
12.4.2 Diagnosis of Causative Agents/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.5.1 Company Overview
12.5.2 Diagnosis of Causative Agents Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 OPKO HEALTH INC.
12.6.1 Company Overview
12.6.2 Diagnosis of Causative Agents Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 PTC Therapeutics
12.7.1 Overview
12.7.2 Diagnosis of Causative Agents Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEO’s View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Dravet Syndrome Industry
Chapter 14 Appendix
LIST OF TABLES
Table 1 Dravet Syndrome Industry Synopsis, 2023 – 2030
Table 2 Dravet Syndrome Market Estimates and Forecast, 2023 – 2030, (USD Million)
Table 3 Dravet Syndrome Market by Region, 2023 – 2030, (USD Million)
Table 4 Dravet Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)
Table 5 Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 6 Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 7 Dravet Syndrome Market by End User, 2023 – 2030, (USD Million)
Table 8 North America Dravet Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)
Table 9 North America Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 10 North America Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 11 North America Dravet Syndrome Market by End User, 2023 – 2030, (USD Million)
Table 12 US Dravet Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)
Table 13 US Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 14 US Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 15 US Dravet Syndrome Market by End User, 2023 – 2030, (USD Million)
Table 16 Canada Dravet Syndrome market by Diagnosis, 2023 – 2030, (USD Million)
Table 17 Canada Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 18 Canada Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 19 Canada Dravet Syndrome market by End User, 2023 – 2030, (USD Million)
Table 20 South America Dravet Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)
Table 21 South America Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 22 South America Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 23 South America Dravet Syndrome Market by End User, 2023 – 2030, (USD Million)
Table 24 Europe Dravet Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)
Table 25 Europe Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 26 Europe Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 27 Europe Dravet Syndrome Market by End User, 2023 – 2030, (USD Million)
Table 28 Western Europe Dravet Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)
Table 29 Western Europe Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 30 Western Europe Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 31 Western Europe Dravet Syndrome Market by End User, 2023 – 2030, (USD Million)
Table 32 Eastern Europe Dravet Syndrome market by Diagnosis, 2023 – 2030, (USD Million)
Table 33 Eastern Europe Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 34 Eastern Europe Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 35 Eastern Europe Dravet Syndrome Market by End User, 2023 – 2030, (USD Million)
Table 36 Asia Pacific Dravet Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)
Table 37 Asia Pacific Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 38 Asia Pacific Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 39 Asia Pacific Dravet Syndrome market by End User, 2023 – 2030, (USD Million)
Table 40 The Middle East & Africa Dravet Syndrome Market by Diagnosis, 2023 – 2030, (USD Million)
Table 41 The Middle East & Africa Dravet Syndrome Market by Type of Seizures, 2023 – 2030, (USD Million)
Table 42 The Middle East & Africa Dravet Syndrome Market by Treatment & Management, 2023 – 2030, (USD Million)
Table 43 The Middle East & Africa Dravet Syndrome market by End User, 2023 – 2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Dravet Syndrome Market
Figure 3 Segmentation Market Dynamics for Dravet Syndrome Market
Figure 4 Global Dravet Syndrome market Share, by Diagnosis 2023
Figure 5 Global Dravet Syndrome market Share, by Type of Seizures 2023
Figure 6 Global Dravet Syndrome market Share, by Treatment & Management 2023
Figure 7 Global Dravet Syndrome market Share, by End User, 2023
Figure 8 Global Dravet Syndrome market Share, by Region, 2023
Figure 9 North America Dravet Syndrome market Share, by Country, 2023
Figure 10 Europe Dravet Syndrome market Share, by Country, 2023
Figure 11 Asia Pacific Dravet Syndrome market Share, by Country, 2023
Figure 12 Middle East & Africa Dravet Syndrome market Share, by Country, 2023
Figure 13 Global Dravet Syndrome market: Company Share Analysis, 2023 (%)
Figure 14 Biocodex: Key Financials
Figure 15 Biocodex: Segmental Revenue
Figure 16 Biocodex: Geographical Revenue
Figure 17 Biscayne Neurotherapeutics: Key Financials
Figure 18 Biscayne Neurotherapeutics: Segmental Revenue
Figure 19 Biscayne Neurotherapeutics: Geographical Revenue
Figure 20 GW Pharmaceuticals, plc: Key Financials
Figure 21 GW Pharmaceuticals, plc: Segmental Revenue
Figure 22 GW Pharmaceuticals, plc: Geographical Revenue
Figure 23 Zogenix, Inc: Key Financials
Figure 24 Zogenix, Inc: Segmental Revenue
Figure 25 Zogenix, Inc: Geographical Revenue
Figure 26 TAKEDA PHARMACEUTICAL COMPANY LIMITED: Key Financials
Figure 27 TAKEDA PHARMACEUTICAL COMPANY LIMITED: Segmental Revenue
Figure 28 TAKEDA PHARMACEUTICAL COMPANY LIMITED: Geographical Revenue
Figure 29 OPKO HEALTH INC.: Key Financials
Figure 30 OPKO HEALTH INC.: Segmental Revenue
Figure 31 OPKO HEALTH INC.: Geographical Revenue
Figure 32 PTC Therapeutics: Key Financials
Figure 33 PTC Therapeutics: Segmental Revenue
Figure 34 PTC Therapeutics: Geographical Revenue
